Abstract
Nowadays, glycation induced protein aggregation and related opposing strategies have received much attention. We present the effect of functionalized magnetic core–shell nanoparticles of Fe3O4 (MNPs) with β-cyclodextrin (β-CD) on the aggregation/fibrillation of bovine serum albumin (BSA) under diabetic condition known as amyloidogenesis. To confirm the β-CD conjugation on MNP, Fourier transform infrared spectroscopy (FTIR), X-ray diffraction (XRD), thermogravimetric analysis (TGA), transmission electron microscopy (TEM) and vibrating sample magnetometer (VSM) methods were applied. Moreover, spectrofluorimetry and spectropolarimetry were utilized to analyze the effect of β-CD/Fe3O4 MNPs on the aggregation and amyloidogenesis of BSA through glycation. The BSA amyloidogenesis was significantly inhibited by interfering β-CD-MNPs that may present the possible diagnostic and preventive applications against the degenerative effects of protein glycation/fibrillation under diabetes.
Keywords: Aggregation, β-cyclodextrin, diabetes, fibrillation, magnetic nanoparticles.
Graphical Abstract
Protein & Peptide Letters
Title:Prevention of Serum Albumin Glycation/Fibrillation by β-Cyclodextrin Functionalized Magnetic Nanoparticles
Volume: 22 Issue: 7
Author(s): Mojtaba Ansari, Mehran Habibi-Rezaei*, Soheila Salahshour-Kordestani, Ali A. Moosavi Movahedi and Najmeh Poursasan
Affiliation:
- School of Biology, College of Science, University of Tehran, Tehran, Iran.,Iran
Keywords: Aggregation, β-cyclodextrin, diabetes, fibrillation, magnetic nanoparticles.
Abstract: Nowadays, glycation induced protein aggregation and related opposing strategies have received much attention. We present the effect of functionalized magnetic core–shell nanoparticles of Fe3O4 (MNPs) with β-cyclodextrin (β-CD) on the aggregation/fibrillation of bovine serum albumin (BSA) under diabetic condition known as amyloidogenesis. To confirm the β-CD conjugation on MNP, Fourier transform infrared spectroscopy (FTIR), X-ray diffraction (XRD), thermogravimetric analysis (TGA), transmission electron microscopy (TEM) and vibrating sample magnetometer (VSM) methods were applied. Moreover, spectrofluorimetry and spectropolarimetry were utilized to analyze the effect of β-CD/Fe3O4 MNPs on the aggregation and amyloidogenesis of BSA through glycation. The BSA amyloidogenesis was significantly inhibited by interfering β-CD-MNPs that may present the possible diagnostic and preventive applications against the degenerative effects of protein glycation/fibrillation under diabetes.
Export Options
About this article
Cite this article as:
Ansari Mojtaba, Habibi-Rezaei Mehran*, Salahshour-Kordestani Soheila, Moosavi Movahedi Ali A. and Poursasan Najmeh, Prevention of Serum Albumin Glycation/Fibrillation by β-Cyclodextrin Functionalized Magnetic Nanoparticles, Protein & Peptide Letters 2015; 22 (7) . https://dx.doi.org/10.2174/0929866522666150511150827
DOI https://dx.doi.org/10.2174/0929866522666150511150827 |
Print ISSN 0929-8665 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-5305 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Coronary Atherosclerosis and Acute Coronary Syndrome: New Insights from Angioscopic Viewpoints
Vascular Disease Prevention (Discontinued) MicroRNA-mediated Regulation of Angiogenesis
Current Angiogenesis (Discontinued) Innate Inflammatory Responses in Stroke: Mechanisms and Potential Therapeutic Targets
Current Medicinal Chemistry Understanding the Diverse Needs of Children Whose Parents Abuse Substances
Current Drug Abuse Reviews Surgical or Interventional Revascularization in Diabetic Patients with Coronary Artery Disease?
Current Diabetes Reviews Thrombolytic Therapy in Acute Ischemic Stroke - Basic Concepts
Current Vascular Pharmacology Treatment of Mild Cognitive Impairment (MCI)
Current Alzheimer Research Intravitreal Dexamethasone Implant <i>versus</i> Intravitreal Ranibizumab Injection for Treatment of Non-Proliferative Diabetic Macular Edema: A Prospective, Randomized and Blinded Trial
Current Drug Delivery Platelets and Atherothrombosis: Causes, Targets and Treatments for Thrombosis
Current Medicinal Chemistry Insulin Resistance and Hypertension
Current Hypertension Reviews Role of Endothelin in Diabetic Retinopathy
Current Vascular Pharmacology Role of 2-Antiplasmin in Cardiovascular System
Letters in Drug Design & Discovery Circulating Endothelial Cells: Markers and Mediators of Vascular Damage
Current Stem Cell Research & Therapy Anti-TNF Treatment in Rheumatoid Arthritis
Current Pharmaceutical Design Effect of Non-Statin Lipid Lowering and Anti-Obesity Drugs on LDL Subfractions in Patients with Mixed Dyslipidaemia
Current Vascular Pharmacology Editorial (Thematic Issue: Combination Therapy of Vascular Diseases and Fangjiomics: When West Meets East in the Era of Phenomics)
Current Vascular Pharmacology The Role of Diabetes Mellitus in Diseases of the Gallbladder and Biliary Tract
Current Diabetes Reviews The HIV Life Cycle: Multiple Targets for Antiretroviral Agents
Drug Design Reviews - Online (Discontinued) How Recent Patents Have Changed our Clinical Approach in Cardio-Thoracic Surgery
Recent Patents on Regenerative Medicine Individual Triptan Selection in Migraine Attack Therapy
Recent Patents on CNS Drug Discovery (Discontinued)